Perioperative Mitigation of Oxidative Stress with Molecular Hydrogen During Simulated Heart Transplantation in Pigs
Kura Branislav, Bacova Barbara Szeiffova, Barancik Miroslav, Sykora Matus, Okruhlicova Ludmila, Tribulova Narcisa, Bolli Roberto, Kalocayova Barbora, LeBaron Tyler W., Andelova Katarina, Slezak Jan · Advances in Biochemistry in Health and Disease · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
Neutral Summary
In a simulated pig heart-transplantation model, 2% molecular hydrogen during anesthesia and extracorporeal circulation was associated with lower selected injury, lipid-peroxidation, and inflammatory markers and with improved functional measures. These findings are preclinical and indicate therapeutic potential under the tested surgical conditions; further human research is needed to determine clinical safety and benefit.
Study Design and Population
Porcine model
Hydrogen Intervention
Other or not reported
Additional Notes
H2HUBB TAKEAWAY
In a simulated pig heart-transplantation model, 2% molecular hydrogen during anesthesia and extracorporeal circulation was associated with lower selected injury, lipid-peroxidation, and inflammatory markers and with improved functional measures. These findings are preclinical and indicate therapeutic potential under the tested surgical conditions; further human research is needed to determine clinical safety and benefit.
How the Study Was Conducted
Pigs underwent a simulated heart-transplantation and extracorporeal-circulation protocol with perioperative physiological, biochemical, inflammatory, and cardiac-function measurements.
How Molecular Hydrogen Was Used
The experimental condition used 2% molecular hydrogen during anesthesia and extracorporeal circulation; control animals underwent the study protocol without that hydrogen exposure.
What the Researchers Found
The hydrogen condition showed lower selected ischemic-injury, lipid-peroxidation, and inflammatory markers, improved pumping measures, and less defibrillation in the simulated transplant model.
Authors’ Conclusion
These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.
Study Limitations
This was a controlled pig experiment with a simulated transplantation protocol. Species differences, procedural conditions, sample size, and short follow-up prevent direct conclusions about human transplant outcomes.
H2HUBB Evidence Boundary
This is a preclinical pig heart-transplantation simulation, not a human transplant trial. The findings justify further research but cannot establish human perioperative efficacy or safety.